Sustainable Integration of US Food and Drug Administration-Approved Biosimilars: Pharmacy- Versus Physician-Driven Change.

David Michael Waterhouse Patrick J Ward David R DrosickCaleb BurdetteDaniel DaviesMolly A Mendenhall

Published in: JCO oncology practice (2023)

Pharmacy-driven auto-substitution of biosimilar products results in rapid and statistically significant biosimilar adoption. The pharmacy-based substitution approach was found to be far more effective than physician-driven substitution. Rapid conversion from branded products to FDA-approved biosimilar is feasible, measurable, and sustainable and can be scaled. Barriers to Neulasta conversion warrant further investigation.

Keyphrases

drug administration
primary care
emergency department
loop mediated isothermal amplification
climate change
sensitive detection